arsenic has been researched along with Sarcoma 180 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, L; Cao, XL; Li, HY; Ma, YP; Wu, ZR; Xie, QJ | 1 |
Bai, L; Li, HY; Wang, X; Xie, QJ; Zhang, X | 1 |
Li, CW; Li, RL; Li, YS; Ma, YY; Tan, W; Wei, ZR; Zhang, TD; Zhao, XL | 1 |
3 other study(ies) available for arsenic and Sarcoma 180
Article | Year |
---|---|
Anti-tumor effects and apoptosis induction by Realgar bioleaching solution in Sarcoma-180 cells in vitro and transplanted tumors in mice in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenicals; Cell Cycle; Cell Proliferation; Chemistry, Pharmaceutical; Drugs, Chinese Herbal; Flow Cytometry; In Vitro Techniques; Metallurgy; Mice; Neoplasm Transplantation; Sarcoma 180; Solutions; Sulfides; Water | 2014 |
[The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
Topics: Animals; Antineoplastic Agents; Arsenicals; Carcinoma, Ehrlich Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Lethal Dose 50; Male; Mice; Random Allocation; Sarcoma 180; Sulfides; Survival Rate | 2009 |
[Traditional Chinese and Western medicine in the treatment of 27 patients with malignant lymphoma].
Topics: Adolescent; Adult; Animals; Arsenicals; Carcinoma, Ehrlich Tumor; Drug Compounding; Drugs, Chinese Herbal; Female; Humans; Lymphoma; Male; Mercury; Mice; Middle Aged; Sarcoma 180; Sarcoma 37 | 1988 |